PRIMECAP Management trim RHYTHM PHARMACEUTICALS, INC.
PRIMECAP Management trim $300.2M of disclosed value in RHYTHM PHARMACEUTICALS, INC..
Signal
Investor Move
Action
Trim
Capital
$300.2M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.